FIELD: medicine, dermatology. SUBSTANCE: agent is made as capsules and comprises fluconazole as active substance and lactose, maize starch, colloidal silicon oxide, magnesium stearate and sodium lauryl sulfate as accessory substances taken in the definite ratio of components. Medicinal agent named as "FLUSOL" is fluconazolebase preparation of domestic industry. Agent provides treatment of sickness of wide spectrum and does not cause pathological alternations in visceral organs in oral intake. EFFECT: enhanced effectiveness of agent, valuable medicinal properties. 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICATION POSSESSING ANTIFUNGAL ACTIVITY | 2008 |
|
RU2397765C2 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTIFUNGAL ACTIVITY, AND METHOD FOR PREPARING IT | 2012 |
|
RU2497521C1 |
| METHOD FOR TREATMENT OF RECURRENT VULVOVAGINAL CANDIDIASIS | 2016 |
|
RU2642666C1 |
| METHOD OF STOMACH ULCER TREATMENT | 2006 |
|
RU2329810C1 |
| ANTIFUNGAL AGENT "BRIZORAL" | 2002 |
|
RU2205008C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING FLUCONAZOLE AND/OR KETOCONAZOLE AND/OR TERBINAFINE, AND LIPOSOMES FOR LOCAL ADMINISTRATION | 2010 |
|
RU2485955C2 |
| METHOD OF TREATING OROPHARYNGEAL CANDIDIASIS IN HIV-INFECTED PATIENTS IN ADVANCED STAGES OF DISEASE | 2017 |
|
RU2715230C2 |
| METHOD OF TREATING ULCEROUS DISEASE OF DUODENUM IN CHILDREN, ASSOCIATED WITH FUNGUS OF GENUS Candida | 2009 |
|
RU2416405C1 |
| METHOD FOR TREATMENT OF RELAPSING UROGENITAL CANDIDIASIS ON BACKGROUND OF TRICHOMONIASIS | 2001 |
|
RU2212238C2 |
| NEW POTENTIAL ANTIFUNGAL AGENTS BASED ON THIAZOLIDINE-2,4-DIONE AND TRIAZOLE | 2023 |
|
RU2814730C1 |
